glp 1 or glp 2 what's the difference between and GLP-1-based therapies: current knowledge of differences between native GLP-1-based therapies for type 2

It's nothing insurmountable, but it does require a little forward planning

Cooper DH, Ramachandra R, Ceban F, et al

Consideration for holding tirzepatide may be appropriate in specific high-risk scenarios, such as patients with significant gastrointestinal symptoms, those early in the titration process, or those undergoing procedures with high risk of gastrointestinal complications

7 It has been shown that GLP-1 receptors in the choroid plexus alter Na+/K+-ATPase activity, which directly influences CSF production and may reduce ICP without exclusively depending on weight reduction

Microdosing is an alternative that involves taking a prescribed low dose